Developmental Surveillance, Screening, and Diagnostic Evaluation

Introduction

• The global prevalence of developmental delay in children is estimated at 1-3%, with the World Health Organization estimating that 15% of the world's population lives with some form of disability.
• In lower and middle-income countries (LMICs) like India, improving maternal and neonatal survival has led to a large cohort of children at high risk for developmental delay due to poverty, malnutrition, ill-health, and lack of early stimulation.
• Developmental surveillance is a continuous, longitudinal, flexible, and comprehensive process that includes all activities related to the detection of developmental problems during primary child health care visits.
• Surveillance comprises eliciting parental concerns, acquiring a detailed developmental history, identifying risk and protective factors, making accurate observations of the child, and maintaining records,.
• Developmental screening is a brief, cross-sectional testing procedure designed to identify children from an apparently normal population who are at high risk for developmental delays and require more intensive diagnosis or assessment,,.
• Screening utilizes standardized, validated developmental tools with established psychometric properties to systematically quantify skills, thereby improving the identification rate of developmental delays from less than 30% (with surveillance alone) to 70-90%,.
• Developmental assessment or diagnostic evaluation refers to a more detailed, comprehensive, and definitive investigation of a child identified as delayed by screening, and it is entirely diagnostic in scope.
• The objective of a psychiatric or neurodevelopmental diagnostic evaluation is to establish an explanatory formulation, provide a differential diagnosis, determine if treatment is indicated, and develop a comprehensive multidisciplinary treatment plan.

Approaches to Developmental Screening

• Fulfilling the goal of early identification requires pediatricians to be skilled in screening methodologies, recognizing that screening does not mean administering a single test at one point in time, but rather utilizing a set of procedures over a period of time.
• Informal screening relies on observing the child during a routine pediatric check-up and casually asking parents about developmental concerns while using the upper limits of normalcy as cut-off points.
• Informal screening is highly insensitive; pediatricians are often inaccurate in their overall estimates of developmental status, and almost half of the children with developmental disabilities are missed by this method.
• Routine formal screening entails the systematic developmental screening of all children using standardized screening instruments.
• In developing countries like India with enormous populations, routine formal screening of every child is highly time-consuming, requires a large trained workforce, and is neither feasible nor cost-effective given the low incidence of problems in low-risk populations.
• Focussed screening involves the targeted administration of developmental screening tests to specific groups, such as children whose parents express developmental concerns or children with established high-risk factors.
• The American Academy of Pediatrics (AAP) currently recommends developmental surveillance at every health visit from birth to 3 years, and routine formal screening of all children at 9, 18, and 24 or 30 months, or earlier if concerns are elicited,.

Differences Between Developmental Screening and Diagnostic Evaluation

Rationale for Screening

• In India, multiple challenges hinder the practice of universal developmental surveillance and screening, primarily because parents are unaware of these services and health care seeking is strongly prioritized for acute illnesses.
• A study of pediatricians in Gujarat revealed that while 97.3% reported parents expressing developmental concerns, only 13.6% used structured tools for evaluation.
• Pediatricians cite severe time constraints (72%), lack of available treatment or referral options (45%), and inability to appropriately use screening tools (28%) as primary reasons for relying on inaccurate informal assessments.
• Formal developmental screening and assessment training is currently lacking in standard post-graduate pediatric curricula in India, leaving pediatricians cognitively aware but lacking the necessary psychomotor and communication skills.
• Parents' recall of developmental milestones in India is often inaccurate, and parents tend to overestimate language development while under-rating fine motor skills, making parental interview alone less reliable in LMICs due to varying literacy levels and social stigma,.
• The Government of India launched the Rashtriya Bal Swasthya Karyakram (RBSK) in 2013, which aims to screen for 4 D’s: Defects at birth, Diseases, Deficiencies, and Developmental delays including disabilities in children from 0 to 18 years.
• Under RBSK, pre-school children are screened by Anganwadi workers using age-appropriate checklists in the periphery, and positive cases are referred for re-assessment by trained personnel at secondary and tertiary care levels.
• The implementation of such national programs inevitably leads to an upsurge in pediatric consultations by concerned parents, requiring pediatricians to be equipped with appropriate tools to tackle these referrals responsibly.

Psychometric Standards for Developmental Tools in India

• To make educated decisions regarding the quality of a tool for Indian office practice, pediatricians must understand the acceptable standards of psychometric parameters.
• Standardization: The tool must have a uniform procedure for administration and scoring, validated on a representative population of healthy children devoid of development-averse conditions like malnutrition and severe anemia,.
• Validity: The ability of a tool to assess what it is intended to assess in comparison with a gold standard diagnostic tool, with an acceptable standard being greater than 70%.
• Sensitivity: The percentage of children with a developmental delay or problem who are correctly identified by the screening test; the acceptable standard is 70-80%.
• Specificity: The percentage of typically developing children who are correctly identified as normal by the screening test; the acceptable standard is 80% or higher to prevent undue parental anxiety and over-referral.
• Positive Predictive Value (PPV): The percentage of children identified as delayed by the screening test who genuinely have the delay upon diagnostic evaluation; the acceptable standard is 30-50%.
• Reliability: How consistently similar results are obtained repeatedly, measured by inter-rater reliability (coefficients >0.60) and test-retest reliability.

Developmental Screening Tools in the Indian Context

International Tools and Their Applicability

• An ideal screening tool for Indian children would be brief, inexpensive, possess excellent psychometric properties, be available in local Indian languages, feature culturally adapted items, and require minimal training.
• The Denver Developmental Screening Test (DDST / Denver II) is a globally popular tool used to screen children from birth to 6 years across gross motor, fine motor, language, and personal-social domains.
• However, the DDST has a highly suboptimal specificity (43-80%), which leads to massive over-identification of false positives, causing unnecessary parental apprehension and overburdening the diagnostic referral system,.
• The Bayley Infant Neurodevelopmental Screen (BINS) assesses neurological processes and cognitive functions in children aged 3 to 24 months, but it lacks validation in Indian children and cannot be used beyond 2 years of age,.
• The Ages and Stages Questionnaire (ASQ) is a parent-completed questionnaire spanning 1 to 66 months, assessing communication, gross motor, fine motor, problem-solving, and personal-adaptive skills.
• The ASQ has been successfully validated in India after translation into Hindi and the substitution of culturally inappropriate items; when administered by an interviewer to Indian parents, it demonstrated a high sensitivity of 83.3%, specificity of 75.4%, and a negative predictive value of 84.6%.
• Parents' Evaluation of Developmental Status (PEDS) utilizes parental concerns to categorize children into high, moderate, or low risk for developmental disabilities; however, a study in India found its psychometric properties to be sub-optimal when compared to the Developmental Profile II, suggesting it should primarily be used to identify children requiring more in-depth screening when time is constrained.

Indigenous Indian Screening Tools

• Indian screening tools were primarily designed for community surveys by health workers but are highly applicable to pediatric office practice as they are culturally appropriate, inexpensive, and standardized on representative local populations.
• Trivandrum Developmental Screening Chart (TDSC): Developed at the Child Development Centre, Kerala, it screens children from 0-2 years (and an extended version up to 6 years) in mental and motor domains,.
• The TDSC consists of 17 to 51 items (depending on the age version) represented by horizontal lines where the left end indicates 3% of children passing the item and the right end indicates 97% passing,.
• The TDSC is extremely rapid (takes 5 minutes), requires minimal training, and is interpreted by drawing a vertical line at the child's chronological age; failure to achieve items to the left of the line indicates developmental delay,.
• Baroda Developmental Screening Test (BDST): Developed from the Bayley Scales of Infant Development (Baroda Norms), it screens infants from 0 to 30 months across motor and cognitive domains,.
• The BDST contains 54 items, takes approximately 10 minutes to administer directly, and reports an age equivalent and developmental quotient, demonstrating a sensitivity of 65-93% and specificity of 77.4-94.4%.
• INCLEN Neurodevelopmental Screening Test (NDST): A comprehensive tool developed by Indian neurodevelopmental experts to screen for 10 specific neurodevelopmental disorders (NDDs) including Autism Spectrum Disorders, ADHD, Intellectual Disability, Cerebral Palsy, and sensory impairments.
• The INCLEN NDST is validated for children aged 2-9 years, and positive screens are sequentially applied to Consensus Clinical Criteria algorithms for definitive diagnosis; multi-centric validation in India revealed an NDD prevalence of 7.5-18.5% using this tool.
• Guide for Monitoring Child Development (GMCD): Originally developed in Turkey, this parental report-based monitoring tool takes 5-10 minutes, covers children from 0 to 3.5 years, and is currently undergoing international standardization including extensive testing in India.

Definitive Diagnostic Evaluation Tests

• Children who fail a developmental screening test must be referred for a definitive diagnostic assessment to accurately define the impairment, calculate a Developmental Quotient (DQ) or Intelligence Quotient (IQ), and formulate a domain-specific intervention plan,.
• Diagnostic evaluation requires a multidisciplinary team comprising a pediatric neurologist, developmental pediatrician, clinical psychologist, speech therapist, occupational therapist, and audiologist.
• Development Assessment Scale for Indian Infants (DASII): An Indian adaptation of the Bayley Scales used for definitive testing from birth to 30 months.
• The DASII takes 45-60 minutes to administer and provides detailed assessments across a motor domain (67 items) and a mental/cognitive domain (163 items).
• Bayley Scales of Infant and Toddler Development, Fourth Edition (BSID-4): The most widely used international infant intelligence test, providing assessment of cognitive, language, motor, social-emotional, and adaptive abilities for children aged 16 days to 42 months,.
• Wechsler Intelligence Scales: Used for older children. The Wechsler Preschool and Primary Scale of Intelligence (WPPSI-IV) is used for mental ages 2.5 to 7.6 years, and the Wechsler Intelligence Scale for Children (WISC-V) is used for children functioning above a 6-year mental age.
• Adaptive Behavior Scales: To formally diagnose Intellectual Disability, IQ scores must be corroborated with adaptive functioning deficits. The Vineland Adaptive Behavior Scale (VABS-3) uses semi-structured interviews with caregivers to assess communication, daily living skills, socialization, and motor skills,.
• Clinical Linguistic and Auditory Milestone Scale (CLAMS) & Clinical Adaptive Test (CAT): Yields quantitative developmental quotients for language (CLAMS DQ) and non-language visual-motor abilities (CAT DQ) from 1 to 36 months, helping discriminate isolated language disorders from global intellectual disability.

Clinical Application: Phenotypes of Developmental Delay

• During diagnostic evaluation, the pediatrician must differentiate between specific patterns of developmental abnormality: delay, dissociation, deviance, and regression.
• Developmental Delay: Development occurs in its usual sequence but at a significantly slower rate (e.g., milestones achieved later than the normal range), resulting in a DQ below 70.
• Global Developmental Delay (GDD): Significant delay (more than 2 standard deviations below the mean) in two or more developmental domains in a child under 5 years of age.
• Developmental Dissociation: The acquisition of milestones at markedly differing rates across various domains. For example, a child with normal gross and fine motor skills but severe expressive language delay (suggesting hearing impairment or specific language disorder),,.
• Developmental Deviance: The acquisition of milestones in an abnormal sequence. For example, a child with spastic diplegic cerebral palsy who stands with support (due to increased extensor tone) before learning to sit independently.
• Developmental Regression: The loss of previously acquired developmental skills. This is a severe red flag indicating a possible neurodegenerative disorder, metabolic condition, severe epileptic encephalopathy (like Landau-Kleffner syndrome), or specific phenotypes of Autism Spectrum Disorder,.

Medical, Audiologic, and Genetic Investigations during Evaluation

• The diagnostic evaluation goes beyond psychometric testing and mandates a thorough medical, neurological, genetic, and metabolic workup based on the clinical phenotype,.
• Vision and Hearing: A complete audiologic assessment and ophthalmologic evaluation are mandatory for any child with language delay or global developmental delay, as sensory impairments can perfectly mimic intellectual disability,,.
• Genetic Evaluation: Chromosomal Microarray Analysis (CMA) has replaced karyotyping as the first-tier genetic test for unexplained global developmental delay, intellectual disability, and Autism Spectrum Disorder,.
• Fragile X DNA testing is recommended in males with GDD/ID, and MECP2 gene sequencing should be considered in females presenting with regression and severe intellectual disability (Rett Syndrome),.
• If microarray and Fragile X testing are non-diagnostic, Whole Exome Sequencing (WES) is increasingly used to identify monogenic etiologies, resulting in a higher diagnostic yield and cost-effectiveness.
• Neuroimaging: Magnetic Resonance Imaging (MRI) of the brain is indicated if the developmental delay is accompanied by microcephaly, macrocephaly, asymmetric head shape, new focal neurologic findings, or seizures,.
• Metabolic Testing: Serum creatine kinase (CK) and thyroid function tests are recommended for children with gross motor delay and hypotonia.
• Comprehensive metabolic screening (plasma amino acids, urine organic acids, acylcarnitine profile) is reserved for children exhibiting developmental regression, episodic encephalopathy, ataxia, or unexplained severe hypotonia,.

Office Practice

• Establishing a routine screening practice in a busy Indian pediatric clinic involves creating parental awareness through information pamphlets and office displays.
• A highly practical approach to overcome time constraints is to couple developmental screening with pre-existing, scheduled immunization visits (e.g., assessing at the 3.5-month, 9-month, and 18-month vaccination contacts),.
• Step 1: Elicit Concerns & Identify Risk. At every visit, the pediatrician must actively elicit parental concerns and categorize the child based on biological risks (prematurity, low birth weight, asphyxia), genetic risks (family history), and psychosocial risks (poverty, maternal depression, lack of stimulation).
• Step 2: Categorized Surveillance or Screening. For low-risk children without parental concerns, routine developmental surveillance and anticipatory guidance should be maintained.
• For high-risk children or those with active parental concerns, formal screening using a rapid, validated tool like the TDSC or an interviewer-administered ASQ is mandatory,.
• Step 3: Interpreting Transient Signs. At specific ages, such as 3.5 months, transient benign tone abnormalities may be noted; the pediatrician should document these and schedule a repeat visit in one month without causing undue alarm, reserving deep diagnostic evaluation for persistent signs.
• Step 4: Communicate Results. If the screening is negative, the pediatrician must reassure the parents, provide guidance on early stimulation, and schedule the next milestone check.
• If the screening is positive, the implications must be discussed thoroughly, and the child must be referred for a definitive diagnostic evaluation without delay.
• Step 5: Refer Not Defer. It is a common but dangerous pitfall to falsely reassure parents or advise them to "wait and watch" to alleviate anxiety; failing to refer a child who has failed a screening test is considered unethical.
• The initiation of multi-disciplinary early intervention (physical therapy, speech-language therapy, occupational therapy) must proceed in parallel with the diagnostic evaluation, and not be delayed until a definitive medical or genetic diagnosis is established.
• Pediatricians must also familiarize themselves with home-based intervention strategies (such as the WHO/UNICEF 'Care for Development' package or early stimulation CDC models) to empower parents to begin remediation immediately in the home environment.